| abstract |
The present invention relates to novel antihyperlipidemia, obesity suppression, hypocholesterolemic and antidiabetic compounds. More particularly, the present invention relates to novel alkyl carboxylic acids of general formula (I), their stereoisomers, pharmaceutically acceptable salts, and pharmaceutical compositions containing them, where all symbols Is as defined in this description. Another aspect of the present invention provides a compound of general formula (I) and one or more HMG CoA reductase inhibitors; cholesterol absorption inhibitors; in combination with conventional pharmaceutically used carriers, diluents and the like; An object of the present invention is to provide a pharmaceutical composition comprising an obesity suppressant; a lipoprotein disorder therapeutic agent; a hypoglycemic agent: insulin; a biguanide agent; a sulfonylurea; a thiazolidinedione; and double PPARα and γ or a mixture thereof. |